Lidocaine/prilocaine nanoencapsulatedAlternative Names: Nanorap; PB-5109
Latest Information Update: 01 Dec 2015
At a glance
- Originator Biolab Sanus Farmaceutica
- Class Acetanilides; Anilides; Erectile dysfunction therapies; Local anaesthetics; Small molecules
- Mechanism of Action Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Anaesthesia
Most Recent Events
- 01 Dec 2015 Phase-III development for Anaesthesia is ongoing in Brazil